Skip to content

ZyVersa Therapeutics, Inc.

ZVSA · OTCM

CIK 1859007fmd_1JXYPAFQTDQE9NHASCQC8NVS2XManufacturing · Pharmaceutical PreparationsTemplate: Standard

Coverage: Jan 01, 2021 to Mar 31, 2026, 20 periods

AI-written

A model wrote this from the company's own SEC filings and our standardized facts. It is not reported fact, not an analyst's estimate, not a rating and not investment advice. Every claim shows what it rests on.

Loading